Published in EuroIntervention on May 01, 2010
Ultrasound and light: friend or foe? On the role of intravascular ultrasound in the era of optical coherence tomography. Int J Cardiovasc Imaging (2011) 0.83
Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples. PLoS One (2011) 0.82
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Protein immobilization strategies for protein biochips. Biomacromolecules (2007) 2.10
Aortoesophageal fistula secondary to stent-graft repair of the thoracic aorta. J Endovasc Ther (2004) 1.85
Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules (2009) 1.80
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
Micromechanical testing of individual collagen fibrils. Macromol Biosci (2006) 1.75
A review on stereolithography and its applications in biomedical engineering. Biomaterials (2010) 1.71
Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol (2004) 1.70
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv (2008) 1.57
Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem (2007) 1.56
Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients. Catheter Cardiovasc Interv (2002) 1.55
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release (2011) 1.52
Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. J Invasive Cardiol (2004) 1.44
Dedicated calibration formulas permit correction of differences between measurements by different IVUS devices as demonstrated in atherosclerotic human coronary arteries in vitro. Int J Cardiovasc Imaging (2006) 1.43
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents. Catheter Cardiovasc Interv (2011) 1.42
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Catheter Cardiovasc Interv (2011) 1.41
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial. Catheter Cardiovasc Interv (2014) 1.40
A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol (2012) 1.40
Effect of oversized partial postdilatation on coatings of contemporary durable polymer-based drug-eluting stents: a scanning electron microscopy study. J Interv Cardiol (2010) 1.39
Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up. Eur Heart J (2006) 1.39
Micromechanical bending of single collagen fibrils using atomic force microscopy. J Biomed Mater Res A (2007) 1.38
Mechanical properties of native and cross-linked type I collagen fibrils. Biophys J (2007) 1.36
Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials (2007) 1.35
Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials (2003) 1.29
Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release (2006) 1.26
Polymersomes for drug delivery: design, formation and characterization. J Control Release (2011) 1.25
Mechanical properties of single electrospun collagen type I fibers. Biomaterials (2008) 1.23
Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J Control Release (2007) 1.21
Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. J Control Release (2005) 1.17
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart (2013) 1.17
A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. J Control Release (2005) 1.16
Validation of human periodontal ligament-derived cells as a reliable source for cytotherapeutic use. J Clin Periodontol (2010) 1.12
A microfluidic wound-healing assay for quantifying endothelial cell migration. Am J Physiol Heart Circ Physiol (2009) 1.10
Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol (2008) 1.09
Delayed cardiac tamponade in a patient with previous minor blunt chest trauma. Int J Cardiol (2007) 1.09
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
The in vivo and in vitro degradation behavior of poly(trimethylene carbonate). Biomaterials (2005) 1.05
Polyethylene glycol-grafted polystyrene particles. J Biomed Mater Res A (2004) 1.05
A poly(D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials (2009) 1.04
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry. EuroIntervention (2012) 1.04
Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules (2007) 1.02
Designed biodegradable hydrogel structures prepared by stereolithography using poly(ethylene glycol)/poly(D,L-lactide)-based resins. J Control Release (2010) 1.01
Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials (2011) 1.01
Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo. Int J Cardiovasc Imaging (2008) 1.01
Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles. J Control Release (2006) 1.00
Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation (2002) 1.00
Biodegradable elastomeric scaffolds for soft tissue engineering. J Control Release (2003) 0.99
Fumaric acid monoethyl ester-functionalized poly(D,L-lactide)/N-vinyl-2-pyrrolidone resins for the preparation of tissue engineering scaffolds by stereolithography. Biomacromolecules (2009) 0.99
Mixtures of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)-g-poly(ethylene glycol) for improved gene delivery. Bioconjug Chem (2010) 0.97
Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation (2004) 0.96
Aspiration of embolized thrombus during primary percutaneous coronary intervention. Catheter Cardiovasc Interv (2009) 0.95
Advanced contour detection for three-dimensional intracoronary ultrasound: a validation--in vitro and in vivo. Int J Cardiovasc Imaging (2002) 0.95
Effects of the architecture of tissue engineering scaffolds on cell seeding and culturing. Acta Biomater (2010) 0.95
Mathematically defined tissue engineering scaffold architectures prepared by stereolithography. Biomaterials (2010) 0.94
In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers. Biomacromolecules (2006) 0.94
Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-to-moderate coronary atherosclerosis: an international multicentre study. EuroIntervention (2010) 0.93
Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. Eur J Echocardiogr (2011) 0.92
The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation. Biomaterials (2012) 0.92
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial. J Am Coll Cardiol (2013) 0.92
Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. J Control Release (2013) 0.91
Controlled and stereoselective polymerization of lactide: kinetics, selectivity, and microstructures. J Am Chem Soc (2003) 0.90
In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). J Control Release (2004) 0.90
Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device. Catheter Cardiovasc Interv (2003) 0.90
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules (2005) 0.90
Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method. Biomaterials (2004) 0.90
Influence of amide versus ester linkages on the properties of eight-armed PEG-PLA star block copolymer hydrogels. Biomacromolecules (2010) 0.90
Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties. J Control Release (2008) 0.89
Biological characterisation of vascular grafts cultured in a bioreactor. Biomaterials (2005) 0.89
The influence of the scaffold design on the distribution of adhering cells after perfusion cell seeding. Biomaterials (2011) 0.89
Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials (2007) 0.89
Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. J Control Release (2007) 0.89
In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. J Control Release (2007) 0.88
Preparation of interconnected highly porous polymeric structures by a replication and freeze-drying process. J Biomed Mater Res B Appl Biomater (2003) 0.88
Preparation of biodegradable networks by photo-crosslinking lactide, epsilon-caprolactone and trimethylene carbonate-based oligomers functionalized with fumaric acid monoethyl ester. Biomaterials (2005) 0.88
Isolated "superdominant" single coronary artery: a particularly rare coronary anomaly. Heart (2007) 0.87
Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. Bioconjug Chem (2010) 0.87
Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol (2007) 0.87
[(salen)Al]-Mediated, controlled and stereoselective ring-opening polymerization of lactide in solution and without solvent: synthesis of highly isotactic polylactide stereocopolymers from racemic D,L-lactide. Angew Chem Int Ed Engl (2002) 0.87
Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol (2006) 0.87
Two cases of pancreatic tuberculosis in nonimmunocompromised patients. A diagnostic challenge and a rare cause of portal hypertension. Pancreatology (2002) 0.87
Biomechanical properties of carbodiimide crosslinked collagen: influence of the formation of ester crosslinks. J Biomed Mater Res A (2008) 0.86
Thermosensitive hydrogel-containing polymersomes for controlled drug delivery. J Control Release (2010) 0.86
Design of segmented poly(ether ester) materials and structures for the tissue engineering of bone. J Control Release (2002) 0.86
Adhesion and growth of human Schwann cells on trimethylene carbonate (co)polymers. J Biomed Mater Res A (2003) 0.85
Physical properties of high molecular weight 1,3-trimethylene carbonate and D,L-lactide copolymers. J Mater Sci Mater Med (2003) 0.85
α-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applications. Biomacromolecules (2011) 0.85
Ectopic bone formation in cell-seeded poly(ethylene oxide)/poly(butylene terephthalate) copolymer scaffolds of varying porosity. J Mater Sci Mater Med (2007) 0.85
Trimethylene carbonate and epsilon-caprolactone based (co)polymer networks: mechanical properties and enzymatic degradation. Biomacromolecules (2008) 0.85
ICAM-1 and VCAM-1 expression by endothelial cells grown on fibronectin-coated TCPS and PS. J Biomed Mater Res A (2003) 0.85
Physical characterization of vascular grafts cultured in a bioreactor. Biomaterials (2005) 0.84
Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering. Tissue Eng Part A (2010) 0.84
Preparation of flexible and elastic poly(trimethylene carbonate) structures by stereolithography. Macromol Biosci (2011) 0.84
Quantification of carboxyl groups in carbodiimide cross-linked collagen sponges. J Biomed Mater Res A (2007) 0.84
Staged therapeutic approach in spontaneous coronary dissection. Ann Thorac Surg (2007) 0.84